(Press-News.org) A study of 72 mice mothers and their litters suggests a popular pesticide may cause neurodevelopmental disorders in humans. Previous studies have shown that nearly half of the risk for neurodevelopment disorders, including autism, is environmental, but few specific environmental causes have been clearly identified. James Burkett and colleagues exposed mice to low doses of pyrethroid pesticide deltamethrin during pregnancy and lactation. Pups of exposed mothers vocalized less compared to pups of unexposed mothers. As adults, the offspring of exposed mothers showed reduced cognition and increased repetitive behaviors, including repetitive grooming and burying of marbles in cage bedding, compared with the offspring of unexposed mothers. However, there were no differences between groups in terms of sociality. Offspring of exposed mothers also had higher levels of striatal dopamine than the offspring of unexposed mothers. These results suggest that exposure to pyrethroid pesticides during development causes a behavioral phenotype in mice that is relevant to neurodevelopment disorders in humans, according to the authors. Pyrethroid pesticides are widely used in the United States and are found in most urban streams. Up to 70-80% of the US population has pyrethroid metabolites at detectable levels in their blood.
END
Pesticides and neurodevelopment disorders
2023-04-25
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China - BGI Insight
2023-04-25
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors or breast cancer treatment with first-line platinum-based chemotherapy. However, limited research is documented on platinum-based treatment prediction with HRD as a biomarker in ovarian cancer patients, especially in the Chinese population.
This first-ever China prospective cohort study, jointly conducted by BGI Genomics clinical researcher Dr. Shao Di and the Fudan University Shanghai Cancer Center team and published on the Journal of Ovarian ...
NIAID appoints Ted Pierson as new Vaccine Research Center director
2023-04-25
“Ted brings a wealth of knowledge and expertise in virology and human immune responses to viruses. He has played a key role in developing antiviral vaccines and furthering our understanding of important viruses transmitted by mosquitoes and ticks—arboviruses—and how neutralizing antibodies work against flaviviruses, such as Zika virus,” said Acting NIAID Director Hugh Auchincloss, M.D. “He is exceptionally well-suited to lead the VRC and its continued pursuit of innovative basic, translational and clinical discovery.”
Prior to his VRC appointment, Dr. Pierson served as a senior investigator and chief of NIAID’s Laboratory of ...
Ten grants totalling $1 million awarded to support the future of clinical stroke research
2023-04-25
Brain Canada, Heart & Stroke, and the Canadian Stroke Consortium are thrilled to announce the recipients of the 2022 Stroke Clinical Research Catalyst Grants. The purpose of this program is to increase capacity for clinical stroke research within Canada, with an aim to reduce the burden of stroke, prevent recurrence, and improve patient outcomes through clinical research that will improve our understanding of stroke and advance stroke care.
“We are thrilled to be collaborating with two leading organizations ...
Cartesian Therapeutics announces appointment of three world-renowned scientists and engineers as charter members of company's scientific advisory board
2023-04-25
Gaithersburg, MD; April 25, 2023 - Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment of three world-renowned scientists and engineers as charter members of the company’s Scientific Advisory Board (SAB): Prof. Jennifer Elisseeff (Johns Hopkins University), Prof. Andrés García (Georgia Institute of Technology), and Prof. David Mooney (Harvard University).
“These distinguished research leaders bring vast ...
Study shows promising results for immunotherapy targeting skin cancer
2023-04-25
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
The study, published today in Nature Communications by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, investigates whether a novel antibody can target and treat melanomas. The results show that the antibody activates the immune response to fight cancer and slows melanoma growth in mice.
Malignant melanoma is the most aggressive type of skin cancer with poor ...
How do you define shyness? A new study analyzes shyness in children
2023-04-25
What is shyness? Research has shown that shyness is characterized by fear and nervousness in response to social novelty and/or social evaluation. Shyness can manifest on behavioral, affective, and physiological levels, but little is known about how these components cluster. Longstanding theories note that shyness may be conceptualized as a trait that is relatively stable across development, which is described as temperamental shyness. Shyness may also be conceptualized as an emotion that is felt in a certain social situation, which is described as state shyness. To ...
Q & A with Shanna van Trigt, Vrije Universiteit author of “Autistic Traits and Self-Conscious Emotions in Early Childhood” Child Development
2023-04-25
Research shows that given the difficulties in navigating social relationships, children with more autistic traits might be prone to less attuned self-conscious emotions after transgression (displaying less guilt and embarrassment and more shame). A new study released in Child Development by researchers at Vrije Universiteit and the University of Amsterdam investigated for the first time the association between autistic traits and self-conscious emotions of guilt, embarrassment, and shame in young children.
Researchers also further examined ...
Better social drinkers don’t earn more
2023-04-25
Social drinking after work is traditionally seen as an important way to build relationships in East Asia. There’s sometimes even a fear that missing out could leave you on the back foot when climbing the career ladder. However, a joint paper looking at the drinking habits and economic situation of working men in Japan, Taiwan and South Korea has found that those who can drink more do not seem to have a financial leg-up over their alcohol-intolerant and less-drinking colleagues. As almost half of the population in East Asia has some intolerance to alcohol, and with the growth of the sober-curious lifestyle, this result may come as good news to those ...
Highly sensitive Raman probe detects enzyme expression in heterogeneous tissues
2023-04-25
Raman imaging offers a greater potential for detecting multiple enzyme activities than fluorescence imaging, demonstrate Tokyo Tech researchers by developing 9CN-rhodol-based activatable Raman probes using a novel mechanism for Raman signal activation. The strategy allows a synthesis of highly activatable Raman probes with high aggregation and multiplexing ability, making it a promising tool for extending the range of Raman probes for the detection of multiple enzyme activities in heterogeneous biological tissues.
The involvement of enzymes in a wide range of biological activities makes them ideal biomarkers for the detection of diseases. In fact, ...
Investment in education in shrinking cities
2023-04-25
In Japan, many municipalities have suffered from population decline due to low birth rates and an aging population. In 2022, the Japanese population over the age of 65 was 36.21 million, accounting for 28.9% of the total population. In addition, approximately 1,300 shrinking cities are within the 1,700 municipalities in Japan. Moreover, the large number of shrinking cities in Japan is unprecedented on a global scale. As a response to the low birthrate, the Japanese government is discussing “unprecedented” measures to reverse the decline, such as ...